KNOWLEDGE OF RISK FACTORS FOR CERVICAL CANCER AND METHODS OF DIAGNOSIS AND PREVENTION AMONG THE PROFESSIONAL GROUP OF POLISH ARMY PILOTS AND STUDENTS OF THE JOHN PAUL II UNIVERSITY OF BIAŁA PODLASKA

Keywords: Cervical Cancer, HPV Virus, Sexually Transmitted Diseases, Cytology, Prevention, Vaccination

Abstract

Introduction and aim of the study: Cervical cancer is a common malignant tumor of the female reproductive system, developing in the cervix. Currently, cervical cancer is considered curable, provided it is detected at an early stage and appropriate treatment is promptly initiated. This work aims to present the results of research on the level of awareness on the cervical cancer, methods of diagnosis and prevention among the professional group of Polish Army pilots and students of the John Paul II University of Biała Podlaska.

Material and Methods: The study was conducted using an anonymous survey questionnaire. The data was collected between January and April 2025. 121 correctly completed surveys were collected and then analyzed.

Summary: The conducted research results allow us to conclude that the definition of cervical cancer, the risk factors for infection, and the methods of preventing infection are well-known terms for the studied group. Additionally, participants learn about new screening tests for cervical cancer.

References

Rajaram S, Gupta B. Screening for cervical cancer: Choices & dilemmas. Indian J Med Res. 2021 Aug;154(2):210-220. doi: 10.4103/ijmr.IJMR_857_20. PMID: 34854432; PMCID: PMC9131755.

Urszula Wojciechowska, Joanna A. Didkowska, Klaudia Barańska, Marta Miklewska, Irmina Michałek, Paweł Olasek, Agnieszka Jawołowska. MALIGNANT CANCER IN POLAND IN 2022 Warsaw 2024 2022 https://onkologia.org.pl/sites/default/files/publications/2025-02/Nowotwory_2022.pdf.

Wojciechowska U, Barańska K, Miklewska M, Didkowska JA. Cancer incidence and mortality in Poland in 2020. Nowotwory. Journal of Oncology 2023;73(3):129-145. DOI: https://doi.org/10.5603/NJO.2023.0026.

Dawid Rowiński, Jan Baran, Aneta Podczerwińska, Katarzyna Chamera-Cyrek, Oliwia Sikora, Dominika Prokop, Mikołaj Borek, Clara Kuzminski, Wojciech Kupczak, Kamil Marzec, Wiktor Jabłoński, Agnieszka Nawara-Baran. Assessment of women's knowledge about HPV vaccinations. 10.15557/PiMR.2024.0051.

Yang M, Li L, Jiang C, Qin X, Zhou M, Mao X, et al. Co-infection with trichomonas vaginalis increases the risk of cervical intraepithelial neoplasia grade 2–3 among HPV16 positive female: a large population-based study. BMC Infect Dis. 2020;20(1):642.

Cancer Epidemiol Biomarkers Prev. International Collaboration of Epidemiological Studies of Cervical Cancer. Cervical carcinoma and sexual behavior: collaborative reanalysis of individual data on 15,461 women with cervical carcinoma and 29,164 women without cervical carcinoma from 21 epidemiological studies. 2009;18(4):1060–9.

Haverkos HW, Soon G, Steckley SL, Pickworth W. Cigarette smoking and cervical cancer: part I: a meta-analysis. Biomed Pharmacother. 2003;57(2):67–77.

Schiffman M, Castle PE, Jeronimo J, et al. Human papillomavirus and cervical cancer. Lancet. 2007;370(9590):890–907. https://doi. org/10.1016/S0140-6736(07)61416-0.

https://onkologia.org.pl/pl/nowotwor-szyjki-macicy-czym-jest [cited: 20 May 2024]. National Cancer Registry: Cervical Cancer. What is it?

Egawa, N. Papillomaviruses and Cancer: Commonalities and Differences in HPV Carcinogenesis at Different Sites of the Body. Int. J. Clin. Oncol. 2023, 28, 956–964.

Anna Łucyszyn, Andrzej Nowakowski, Mariusz Bidziński, Witold Kędzia, Paweł Knapp, Andrzej Marszałek, Włodzimierz Sawicki, Rafał Stojko, Hubert Wolski, Dariusz Wydra, Mariusz Zimmer, Piotr Sieroszewski, Gynecology and Practical Perinatology, Algorithms for screening tests and procedures for abnormal results within the Cervical Cancer Prevention Program reimbursed by the National Health Fund - edition after the introduction of high-risk human papillomavirus diagnostics. Recommendations of the Expert Team of the Polish Society of Gynecologists and Obstetricians, 2024;9(2):124-132.

OECD/European Commission (2025), National Cancer Profiles,: Polska 2025, National Cancer Profiles, OECD Publishing, Paris, https://doi.org/10.1787/dbc6b1f7-pl.

ORDER No. 46/2025/DSOZ OF THE PRESIDENT OF THE NATIONAL HEALTH FUND of 30 June 2025 amending the order on specifying the conditions for concluding and implementing contracts for the provision of healthcare services such as outpatient specialist care.

Bruni, L.; Albero, G.; Rowley, J.; Alemany, L.; Arbyn, M.; Giuliano, A.R.; Markowitz, L.E.; Broutet, N.; Taylor, M. Global and Regional Estimates of Genital Human Papillomavirus Prevalence among Men: A Systematic Review and Meta-Analysis. Lancet Global Health 2023, 11, e1345–e1362.

Cytology, National Cancer Registry, onkologia.org.pl/pl/cytologia, September 17, 2021.

Osowiecka K, Yahuza S, Szwiec M et al.: Students’ knowledge about cervical cancer prevention in Poland. Medicina (Kaunas) 2021; 57: 1045.

Mędrela- Kuder E. Level of knowledge about risk factors and prevention of cervical cancer among students of selected universities in Kraków., Pol Prz Nauk Zdr. 2014.1(38):20-24.

Patel, C, Brotherton, JM, Pillsbury, A, Jayasinghe, S, Donovan, B, Macartney, K, et al. The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent? Euro Surveill. (2018) 23:1700737. doi: 10.2807/1560-7917.ES.2018.23.41.1700737.

Choi, S, Ismail, A, Pappas-Gogos, G, and Boussios, S. HPV and cervical Cancer: a review of epidemiology and screening uptake in the UK. Pathogens. (2023) 12:298. doi: 10.3390/pathogens12020298.

Baisley K. et al. Comparing one dose of HPV vaccine in girls aged 9–14 years in Tanzania (DoRIS) with one dose of HPV vaccine in historical cohorts: an immunobridging analysis of a randomised controlled trial. Lancet Glob. Heal. 10, e1485–e1493 (2022). pmid:36113532.

Basu P. et al. Vaccine efficacy against persistent human papillomavirus (HPV) 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre, prospective, cohort study. Lancet Oncol. 22, 1518–1529 (2021). pmid:34634254.

Pasmans H. et al. Long-term HPV-specific immune response after one versus two and three doses of bivalent HPV vaccination in Dutch girls. Vaccine 37, 7280–7288 (2019). pmid:31575492.

Petca, A.; Borislavschi, A.; Zvanca, M.E.; Petca, R.-C.; Sandru, F.; Dumitrascu, M.C. Non-Sexual HPV Transmission and Role of Vaccination for a Better Future (Review). Exp. Ther. Med. 2020, 20, 186.

Views:

41

Downloads:

23

Published
2025-11-11
Citations
How to Cite
Anna Mandziuk, Marta Mandziuk, Dorota Roczek, Anastazja Skutta, Natalia Kozerska, Aleksandra Młocek, Angelika Jankowska, Magdalena Mandziuk, & Aleksandra Białas. (2025). KNOWLEDGE OF RISK FACTORS FOR CERVICAL CANCER AND METHODS OF DIAGNOSIS AND PREVENTION AMONG THE PROFESSIONAL GROUP OF POLISH ARMY PILOTS AND STUDENTS OF THE JOHN PAUL II UNIVERSITY OF BIAŁA PODLASKA. International Journal of Innovative Technologies in Social Science, (4(48). https://doi.org/10.31435/ijitss.4(48).2025.4024